Aggressive NHL
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL (NCT01101581) | Gilead Sciences | 2010-05-01 |
Track Aggressive NHL automatically
Every clearance here is in the API, with alerts when new ones post.